Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Phreesia, Inc. (PHR)

31.5   0.51 (1.65%) 03-24 16:00
Open: 30.67 Pre. Close: 30.99
High: 32.26 Low: 30.52
Volume: 817,097 Market Cap: 1,676(M)

Technical analysis

as of: 2023-03-24 4:28:49 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 41.55     One year: 45.38
Support: Support1: 30.26    Support2: 25.18
Resistance: Resistance1: 35.57    Resistance2: 38.86
Pivot: 34.28
Moving Average: MA(5): 33.19     MA(20): 34.92
MA(100): 32.34     MA(250): 27.15
MACD: MACD(12,26): -1     Signal(9): -0.7
Stochastic oscillator: %K(14,3): 17.6     %D(3): 30.8
RSI: RSI(14): 39.1
52-week: High: 40  Low: 13.18
Average Vol(K): 3-Month: 405 (K)  10-Days: 557 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ PHR ] has closed above bottom band by 11.7%. Bollinger Bands are 14.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 32.28 - 32.44 32.44 - 32.6
Low: 30.16 - 30.32 30.32 - 30.48
Close: 31.24 - 31.5 31.5 - 31.76

Company Description

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

Headline News

Mon, 27 Mar 2023
Phreesia, Inc. to Post Q1 2024 Earnings of ($0.83) Per Share, SVB ... - MarketBeat

Thu, 23 Mar 2023
Phreesia Inc Down 7.14% To $31.19 After Earnings Miss - InvestorsObserver

Wed, 22 Mar 2023
Phreesia: Fiscal Q4 Earnings Snapshot - Huron Daily Tribune

Wed, 22 Mar 2023
After-Hours Earnings Report for March 22, 2023 : CHWY, KBH, WOR ... - Nasdaq

Wed, 22 Mar 2023
Markets Today: Stocks Slightly Lower Ahead of FOMC Interest Rate ... - Barchart

Mon, 20 Mar 2023
2023-03-20 | NYSE:PHR | Press Release | Phreesia Inc. - Stockhouse

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 53 (M)
Shares Float 50 (M)
% Held by Insiders 4 (%)
% Held by Institutions 95 (%)
Shares Short 2,300 (K)
Shares Short P.Month 1,310 (K)

Stock Financials

EPS -3.59
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 6.07
Profit Margin (%) -70.4
Operating Margin (%) -69.8
Return on Assets (ttm) -24.8
Return on Equity (ttm) -47.5
Qtrly Rev. Growth 30.7
Gross Profit (p.s.) 2.49
Sales Per Share 4.97
EBITDA (p.s.) -3.12
Qtrly Earnings Growth 0
Operating Cash Flow -112 (M)
Levered Free Cash Flow -68 (M)

Stock Valuations

PE Ratio -8.78
PEG Ratio 0
Price to Book value 5.18
Price to Sales 6.33
Price to Cash Flow -14.81

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.